微门户首页  新闻  讨论区  活动  博客  求职招聘  行业报告  圈内成员  供应   
已读[288] 发布: 2013/06/18 22:10:15
BioNews Texas Two states of pancreatic cancer were considered including metastatic cancer and locally advanced with two treatments including Folfironox (irinotecan, oxaliplatin, leucovorin, and 5-fluorouracil) and gemcitabine . The committee suggests that in the ... and more »
已读[243] 发布: 2013/06/18 22:10:11
Proactive Investors UK It is being used in combination with gemcitabine , the most common chemotherapy, to treat pancreatic cancer, the terminal disease that killed Steve Jobs and Patrick Swayze. The drug developer said the Data Safety Monitoring Board (DSMB) unanimously  ... and more »
已读[240] 发布: 2013/06/18 22:10:07
Proactive Investors UK The candidate is being used in combination with gemcitabine , the most common chemotherapy, to treat pancreatic cancer. Following the update, broker N+1 Singer meanwhile is looking forward to more detail on the company's plans to broaden development  ... and more »
已读[235] 发布: 2013/06/18 22:10:03
4-traders (press release) The Phase Ib/IIa study uses Atu027 in combination with gemcitabine , a chemotherapy agent in patients with advanced pancreatic cancer qualifyi...
已读[593] 发布: 2013/06/18 17:30:58
...注射用氨磷汀为,用于各种癌症放化疗的辅助治疗;广谱抗癌药物氟尿嘧啶注射液,主要用于治疗乳腺癌、消化道癌肿、卵巢癌;新型抗肿瘤药去甲斑蝥酸钠,用于治疗肝癌、食道癌、胃和贲门癌、肺癌及白细胞低下症;缬沙坦氨氯地平胶囊用于控制高血压和心绞痛;...
已读[236] 发布: 2013/06/16 12:15:16
The Oncology Report Median overall survival was 7.9 months for gemcitabine (Gemzar) and capecitabine (Xeloda) chemotherapy alone, 6.9 months for 8 weeks of gemcitabine and capecitabine followed by GV1001 vaccinations until progressive disease then gemcitabine and  ...
已读[289] 发布: 2013/06/15 14:41:23
吉西他滨单药是标准方案,联合化疗优于吉西他滨单药,吉西他滨单药联合靶向药物如特罗凯可改善病人存活。 4、中药治疗 病情一旦发展到了晚期,如果身体情况不好无法...
已读[447] 发布: 2013/06/15 14:41:20
MPACT研究证实蛋白结合型紫杉醇联合吉西他滨在用于转移性胰腺癌患者治疗时,与单纯的吉西他滨方案相比,可取得统计学意义上的改善,并且所有亚组在所有终点上均取得临床...
已读[222] 发布: 2013/06/15 14:39:13
The Oncology Report Median overall survival was 7.9 months for gemcitabine (Gemzar) and capecitabine (Xeloda) chemotherapy alone, 6.9 months for 8 weeks of gemcitabine and capecitabine followed by GV1001 vaccinations until progressive disease then gemcitabine and  ...
已读[240] 发布: 2013/06/15 14:39:03
Insider Monkey (blog) MAESTRO is a Phase III clinical trial of TH-302 in combination with gemcitabine to treat patients with pancreatic cancer. The company is expected to release interim results of these trials in the fall this year with complete results expected in late 2014.
« 上一页  |   查看结果71-80共311   |  下一页 »

新闻标签:

没有标签


最新报告


求职招聘